WeVote
Log In

Bill

Bill

HB 1626

Concerning coverage for colorectal screening tests under medical assistance programs.

2023-2024 Regular Session Introduced by Dan Bronoske and 11 co-sponsors

Washington requires Medicaid to cover colorectal cancer screening tests with zero patient cost-sharing, removing financial barriers to early cancer detection for low-income residents.

Effective date 7/23/2023.
0
WeVote Research Nonpartisan
Bill Summary · HB 1626

Legislative bill overview

HB 1626 requires Washington's medical assistance programs (primarily Medicaid) to cover colorectal screening tests without cost-sharing requirements such as copayments, coinsurance, or deductibles. The bill aligns state coverage with federal preventive care standards that recommend regular colorectal cancer screening for adults aged 45-75.

Why is this important

Colorectal cancer is the second leading cause of cancer death in the U.S., yet it is highly preventable through early screening. Removing financial barriers to screening encourages earlier detection when treatment is most effective and less costly. This affects lower-income Washingtonians who rely on Medicaid and may otherwise delay or skip necessary preventive care due to out-of-pocket costs.

Potential points of contention

  • Cost to state budget: Eliminating cost-sharing increases utilization of screening services, raising state Medicaid expenditures, though early detection may reduce long-term treatment costs
  • Federal alignment debate: While the bill mirrors federal preventive care recommendations, some argue states should have flexibility to impose minimal cost-sharing to discourage unnecessary use
  • Scope limitations: The bill covers screening tests but may not address barriers like transportation, appointment availability, or follow-up care for positive results

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.